Senolytic therapy (SToMP-AD)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Senolytic therapy (SToMP-AD), covering 2026-04-01 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study [Phase 2]